Multidimensional Predictors of Balance in Healthy Young Adults

February 25, 2026 updated by: Hatice Gül, Akdeniz University

Determinants of Static and Dynamic Balance in Healthy Young Adults: A Multidimensional Observational Study

Brief Summary (for ClinicalTrials.gov) This cross-sectional observational study aims to identify independent determinants of static and dynamic balance in healthy young adults using a multidimensional assessment framework. A total of 119 healthy participants (mean age 22.6 ± 1.5 years; 61.3% female) completed standardized static balance tests (Stork Balance Test and Tandem Stance Test under eyes-open and eyes-closed conditions) and a dynamic balance test (Y-Balance Test for right and left limbs). Candidate explanatory factors include foot posture (Foot Posture Index-6), body composition assessed by bioelectrical impedance analysis, general muscle strength (dominant hand grip strength), weight-bearing ankle dorsiflexion range of motion (knee-to-wall/weight-bearing lunge test), functional lower-limb strength (30-second sit-to-stand test), sex, and cognitive performance (Stroop Test Part 5). Multiple linear regression model (enter method) was used to determine which factors independently predict static and dynamic balance outcomes. Findings are expected to clarify which structural, functional, and cognitive variables most strongly contribute to balance performance in healthy young adults, informing targeted assessment and prevention strategies.

Study Overview

Study Type

Observational

Enrollment (Actual)

119

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Konyaaltı
      • Antalya, Konyaaltı, Turkey (Türkiye), 07070
        • Pamukkale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consists of 119 healthy young adults who were voluntarily enrolled (mean age 22.6 ± 1.5 years; 61.3% female).

Description

Inclusion Criteria:

  • age 18-30 years
  • absence of lower extremity
  • absence of vestibular pathology
  • willingness to participate.

Exclusion Criteria:

  • neurological or neuromuscular disorders
  • leg length discrepancy >5 mm
  • visual or auditory impairment
  • history of middle ear infection in the last 6 months
  • recent (<6 months) lower extremity injury
  • Having a fracture
  • Having surgery
  • Having tinnitus
  • Having a persistent headache
  • Current use of medications that may influence balance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy participants
Participants completed standardized static balance tests (Stork Balance Test and Tandem Stance Test under eyes-open and eyes-closed conditions) and dynamic balance assessments using the Y-Balance Test for both right and left limbs. In addition, the following measurements were obtained: foot posture (Foot Posture Index-6), body composition via bioelectrical impedance analysis, general muscle strength (dominant hand grip strength), weight-bearing ankle dorsiflexion range of motion (knee-to-wall/weight-bearing lunge test), functional lower-limb strength (30-second sit-to-stand test), sex, and cognitive performance (Stroop Test Part 5).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stork Balance Test (Eyes Open and Eyes Closed) Time
Time Frame: At a single study visit (baseline)
Time (seconds) maintained in the Stork Balance Test under eyes-open and eyes-closed conditions. Higher values indicate better static balance.
At a single study visit (baseline)
Tandem Stance Test (Eyes Open and Eyes Closed) Time
Time Frame: At a single study visit (baseline)
Time (seconds) maintained in the Tandem Stance Test under eyes-open and eyes-closed conditions. Higher values indicate better static balance.
At a single study visit (baseline)
Y-Balance Test Composite Score (Right and Left)
Time Frame: At a single study visit (baseline)
Y-Balance Test composite score (%) for the right and left lower limbs, calculated from reach distances and normalized to limb length. Higher values indicate better dynamic balance.
At a single study visit (baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foot Posture Index-6 (FPI-6)
Time Frame: Baseline (single assessment session)
Foot posture assessed using the Foot Posture Index-6. Outcome: total FPI-6 score (-12 to +12), with higher scores indicating a more pronated foot posture.
Baseline (single assessment session)
Knee-to-Wall Test (KTW)
Time Frame: Baseline (single assessment session)
Ankle mobility was assessed with the Knee-to-Wall Test (KTW). In this test, functional dorsiflexion flexibility was measured using a tape measure placed on the tip of the foot while the participant attempted to touch the wall with the knee without heel lift.
Baseline (single assessment session)
30-Second Sit-to-Stand Test
Time Frame: Baseline (single assessment session)
Number of full sit-to-stand repetitions completed in 30 seconds. Higher counts indicate better functional lower-limb strength/endurance.
Baseline (single assessment session)
Dominant Hand Grip Strength
Time Frame: Baseline (single assessment session)
General muscle strength was assessed via dominant hand grip strength measurement. Dominant hand grip strength measured using a hand dynamometer. Outcome: mean grip strength (kg) across three trials. Higher values indicate greater general muscle strength.
Baseline (single assessment session)
Stroop Test
Time Frame: Baseline (single assessment session)
Cognitive performance was tested with the Stroop Test-Part 5. In this section, participants were required to name the ink color of incongruent color words rather than reading the words. Completion time was recorded with a stopwatch.
Baseline (single assessment session)
Fat Mass (kilograms) measured by Bioelectrical Impedance Analysis
Time Frame: Baseline (single assessment session)
Fat mass is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms.
Baseline (single assessment session)
Skeletal Muscle Mass (kilograms) measured by Bioelectrical Impedance Analysis
Time Frame: Baseline (single assessment session)
Skeletal muscle mass is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms.
Baseline (single assessment session)
Bone Mass (kilograms) measured by Bioelectrical Impedance Analysis
Time Frame: Baseline (single assessment session)
Bone mass is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms.
Baseline (single assessment session)
Total Body Water (kilograms) measured by Bioelectrical Impedance Analysis
Time Frame: Baseline (single assessment session)
Total body water is measured using bioelectrical impedance analysis (Tanita body composition analyzer) and reported in kilograms.
Baseline (single assessment session)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 25, 2025

Primary Completion (Actual)

January 10, 2026

Study Completion (Actual)

January 10, 2026

Study Registration Dates

First Submitted

February 17, 2026

First Submitted That Met QC Criteria

February 22, 2026

First Posted (Actual)

February 27, 2026

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 25, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 09.09.2025/17

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Adult

Clinical Trials on Participants did not receive any intervention as part of the study; they only underwent assessments.

Subscribe